← Open Payments lookup

YOHANNES WOLDE: Open Payments

NPI 1841045887 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,090 in 189 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,138 · 2025 $5,090

Food & beverage: $5,090
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$925
Otsuka America Pharmaceutical, Inc.23$782
Alkermes, Inc.21$635
Vanda Pharmaceuticals Inc.11$558
ABBVIE INC.27$501
E.R. Squibb & Sons, L.L.C.20$473
Neurocrine BioSciences, Inc.12$362
Janssen Pharmaceuticals, Inc9$234
Supernus Pharmaceuticals, Inc.14$166
Indivior Inc.5$119

Products named: CAPLYTA, ARISTADA, FANAPT, VRAYLAR, REXULTI, COBENFY, INGREZZA, ABILIFY MAINTENA.

Industry payments across NV — which companies pay providers there.